Sep 4, 2014
Cipla introduces Serroflo for respiratory treatment in Germany and Sweden
Cipla introduces Serroflo for respiratory treatment in Germany and Sweden
India-based Cipla has introduced Serroflo (salmeterol/fluticasone MDI) in Germany and Sweden to treat patients suffering from asthma.
Serroflo is expected to improve the affordability of fixed combinations in Europe and help manage health costs for respiratory treatment.
Cipla Europe head Frank Pieters said: “With Serroflo, we offer in Germany and Sweden an alternative, which is…
View On WordPress